 Coherus Biosciences NASDAQ:CHRS was downgraded by stock analysts at BidaskClub from a sell rating to a strong sell rating in a report released on Thursday, BidAskClub reports. Several other analysts have also commented on the stock. Maxim Group started coverage on shares of Coherus Biosciences in a research report on Saturday, May 9th. They issued ... 